- Perpetually Adaptive Enterprise Press tab for submenu items
Where adaptability meets advantage
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
-
Alliances
Perpetually Adaptive Enterprise
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- About Us Press tab for submenu items
We deliver excellence and create value for customers and communities.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
-
Brand
-
Leadership
-
Community
-
Sustainability
-
Inclusion
-
Values
- Customer Stories Press tab for submenu items
Discover why customers choose TCS
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
-
Events
Upcoming events
29 Sep 2025 TCS BaNCS and Quartz at SIBOS 2025, Frankfurt22 Sep 2025 TCS Life Sciences Forum 2025 LondonView all16 Sep 2025 Shaping Tomorrow through AI -
Analyst Recognition
-
Global Studies
- Build a future with us Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Build a future with us
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
Investor Relations
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
- Worldwide Press tab for submenu items
Global knowledge. Local support
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
-
Global
-
Localized sites
Top Results
Showing
10
01 - 07
You have these already downloaded
We have sent you a copy of the report to your email again.
Next-gen technologies can impact the risk-based monitoring in clinical trials.
Considering the growing demands to get better and affordable treatment options, there needs to be a fundamental shift in drug development and specifically the clinical trials oversight processes to mitigate risks and reduce failures. The International Council for Harmonization (ICH) E6 R2 addendum has now provided guidelines for adaptation of risk-based approach to trial conduct and monitoring to implement mitigation strategies and key risk indicators for potential risks which might derail the conduct of the trial. However, with the changing landscape of drug development which includes novel therapies such as gene therapy, decentralized trials, wearable technologies, eSource, electronic health record interoperability, and implementation of AI ML algorithms, the future of risk-based approach towards managing clinical trials is going to be very different from what we see now.
Related reading
1/4
Automation of Trial Design Domains Generation Using AI
Article
|
11 Aug 2025
Opens in new tab
2/4
Solutions
TCS ADD™ Medical Monitoring: Revolutionize Subject Data Analysis
Solution
|
24 Jun 2025
Opens in new tab
3/4
Artificial Intelligence – A Game Changer in Unifying Clinical Data
Article
|
20 May 2025
Opens in new tab
4/4
TCS ADD™ Webinar: Shaping the Future of AI-driven SDTM Harmonization
video
|
22 Apr 2025
Opens in new tab
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?
©2025 TATA Consultancy Services Limited
©2025 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Accessibility Declaration
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
